Ubs Group Ag Aziyo Biologics, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 32,579 shares of AZYO stock, worth $47,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,579
Previous 500
6415.8%
Holding current value
$47,239
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AZYO
# of Institutions
29Shares Held
8.98MCall Options Held
893KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT1.8MShares$2.6 Million0.17% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.7MShares$2.46 Million0.89% of portfolio
-
Silverarc Capital Management, LLC1.6MShares$2.33 Million0.66% of portfolio
-
Birchview Capital, LP Burlington, VT1.55MShares$2.25 Million2.25% of portfolio
-
Perkins Capital Management Inc780KShares$1.13 Million1.11% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...